An example of an operational research question raised by national malaria control programmes (NMCPs) considering concurrent distribution of pyrethroid-CFP and pyrethroid-PBO ITNs was: would the effectiveness of pyrethroid-CFP ITNs be reduced if they were deployed in the same household as pyrethroid-PBO ITNs? This evidence concerns the gene CFP and malaria.